NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 18 filers reported holding NOVUS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | -71.4% | 4,067 | -65.5% | 0.00% | – |
| Q3 2019 | $7,000 | -82.5% | 11,773 | -70.9% | 0.00% | – |
| Q2 2019 | $40,000 | -45.2% | 40,452 | +120.6% | 0.00% | – |
| Q1 2019 | $73,000 | -9.9% | 18,338 | -63.9% | 0.00% | – |
| Q4 2018 | $81,000 | -88.1% | 50,846 | -65.1% | 0.00% | – |
| Q3 2018 | $680,000 | +10.7% | 145,801 | +66.1% | 0.00% | – |
| Q2 2018 | $614,000 | +3511.8% | 87,799 | +2375.3% | 0.00% | – |
| Q1 2018 | $17,000 | – | 3,547 | +88575.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 4 | -98.7% | 0.00% | – |
| Q3 2017 | $1,000 | -94.4% | 315 | -90.4% | 0.00% | – |
| Q2 2017 | $18,000 | – | 3,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,785,000 | $818,000 | 0.05% |
| Orbimed Advisors | 3,183,314 | $1,459,000 | 0.02% |
| Virtu Financial LLC | 92,113 | $42,000 | 0.01% |
| Bayesian Capital Management, LP | 11,601 | $5,000 | 0.00% |
| Private Advisor Group, LLC | 111 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 42,134 | $19,000 | 0.00% |
| ROYAL BANK OF CANADA | 442 | $0 | 0.00% |
| Rockefeller Capital Management L.P. | 30,000 | $14,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 70 | $0 | 0.00% |
| NORTHERN TRUST CORP | 11,527 | $5,000 | 0.00% |